# Contrast Enhanced Transrectal Ultrasonography (TRUS) to Assess Prostatic Vascularity After Radiotherapy (XRT)

> **NCT00635167** · NA · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University** · enrollment: 1 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Contrast Enhanced-Transrectal Ultrasound

## Key facts

- **NCT ID:** NCT00635167
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-06
- **Primary completion:** 2011-05-12
- **Final completion:** 2011-05-12
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Closed by PI final report submitted
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00635167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00635167, "Contrast Enhanced Transrectal Ultrasonography (TRUS) to Assess Prostatic Vascularity After Radiotherapy (XRT)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00635167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*